SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

BRIEF-Aslan Pharmaceuticals Reports Q1 Net Loss Of $6.7 mln

05/11/2021 08:20
BRIEF-Aslan Pharmaceuticals Reports Q1 Net Loss Of $6.7 mln

- Aslan Pharmaceuticals Ltd 7A9y.F:

  • ASLAN PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • ASLAN PHARMACEUTICALS LTD - NEXT DATA READOUT FOR ASLAN004 IN TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS ANTICIPATED IN Q3 2021

  • ASLAN PHARMACEUTICALS LTD - PHASE 2B CLINICAL TRIAL FOR ASLAN004 EXPECTED TO INITIATE IN SECOND HALF OF 2021

  • ASLAN PHARMACEUTICALS LTD - BELIEVES THAT ITS CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2023

  • ASLAN PHARMACEUTICALS LTD - NET LOSS FOR Q1 OF 2021 WAS US$6.7 MILLION COMPARED TO A NET LOSS OF US$3.0 MILLION FOR Q1 OF 2020

Source text for Eikon: ID:nGNX98HtrX

Further company coverage: [7A9y.F]


(([email protected];))